BioPartnering China to help life science firms make local connections

16 February 2009

US business development firm Technology Vision Group has announced at the BioPartnering North America conference its collaboration with  strategic partners to enable foreign lifescience companies to expand  into China. This new initiative, BioPartnering China, aims to facilitate  foreign life science companies to meet their Chinese counterparts in a  professional and organized atmosphere. "TVG is creating an environment  in which the world's best life science companies can meet their Chinese  counterparts to do business together," the firm said. It will  collaborate with the China National Center for Biotechnology Development  in Beijing, a Department of the Ministry of Science and Technology, the  Tianjin Municipal Science and Technology Commission (TSTC), the European  Federation of Biotechnology and BayHelix Group, a Chinese life science  business leaders' association. TVG will also work closely with ChinaBio  which is based in Shanghai, San Diego and Palo Alto.

Robert Kilpatrick, a TVG partner, said, "BioPartnering China represents  our long-term commitment to bring Chinese life science into the global  supply chain." The BioPartnering China event will be held on June 26, in  the Tianjin Special Economic Zone.

A further China networking forum, BioPartnering 2.0, will follow in  London, UK, as part of BioPartnering Europe in October. BioPartnering  3.0 will be a full conference in China in 2010 and will comprise  partnering, conference, networking and an exhibition.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight